FindTrial
Sign In

Study for hemostasis effect of tranexamic acid after hybrid total knee arthroplasty

Study for the application strategy of tranexamic acid in hybrid total knee arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027257
Enrollment
Unknown
Registered
2019-11-06
Start date
2018-09-01
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of knee joint

Interventions

1:fully cemented TKA + intra-articular injection(IAI) of 1g TXA
2:fully cemented TKA+ IAI of 2g TXA
3:hybrid TKA + IAI of 1 g TXA
4:hybrid TKA + IAI of 2g TXA

Sponsors

Zaozhuang Municipal Hospital, Shandong Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
47 Years to 78 Years

Inclusion criteria

Inclusion criteria: 1. Patients with knee osteoarthritis; 2. Aged 65 but BMD > - 1.

Exclusion criteria

Exclusion criteria: 1. Patients who are unwilling to participate in the study; 2. Patients with a long history of taking anticoagulants; 3. Patients with lower extremity vascular diseases; 4. Patients with hematological diseases; 5. Tumor patients

Design outcomes

Primary

MeasureTime frame
routine blood test;HCT;—

Countries

China

Contacts

Public ContactWang Chengbin

Zaozhuang Municipal Hospital, Shandong Province

zzslyywcb@126.com+86 13258965816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026